Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-04-29Correlation Between Relapses in Multiple Sclerosis (MS) and Vitamin D Intake
-
CLINICAL_TRIALS study record update · 2022-04-28Dry Needling for Treating Spasticity in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-04-28A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With Optional Open-Label Extension in Subjects With Relapsing Multiple Sclerosis to Evaluate the Efficacy and Safety of BIIB033 as an Add-On Therapy to Anti-Inflammatory Disease-Modifying Therapies
-
CLINICAL_TRIALS study record update · 2022-04-27A Randomized, Double-Blind, Parallel-Group Study to Assess the Effects of Arbaclofen ER Tablets Compared With Placebo on Sperm Parameters in Male Subjects With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-04-26Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-04-26CSF Free Kappa Light Chain for The Diagnosis of Demyelinating Disorders Taking Oligoclonal Banding Via Isoelectric Focusing Electrophoresis as Gold Standard: A Laboratory Study
-
CLINICAL_TRIALS study record update · 2022-04-25International LEMTRADA Pregnancy Exposure Cohort in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-04-25A Randomized, Double-Blind, Parallel Group Study to Compare the Safety and Efficacy Arbaclofen ER Tablets to Placebo and Baclofen Tablets, USP for the Treatment of Spasticity in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-04-25A One Year, Open Label, Dose Escalation Study To Evaluate the Long-Term Safety of Arbaclofen Extended Release Tablets (AERT) in Multiple Sclerosis Subjects With Spasticity
-
CLINICAL_TRIALS study record update · 2022-04-22Disability, MRI Lesions and Thickness of Retinal Fibers: Evaluation 15 Years After a First Episode of Demyelination
-
CLINICAL_TRIALS study record update · 2022-04-21A Multinational, Multicenter, Randomized, Parallel-Group Study Performed in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Laquinimod Over Placebo in a Double-blind Design and of a Reference Arm of Interferon β-1a (Avonex®) in a Rater-blinded Design
-
CLINICAL_TRIALS study record update · 2022-04-20MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-04-20A Multi-Site Randomized Controlled Trial of MS INFoRm: An Interactive Fatigue Management Resource for Persons With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-04-18Evaluation of the Prevalence of Oculomotor Disorders in Patients With Radiologically Isolated Syndrome
-
CLINICAL_TRIALS study record update · 2022-04-18Effectiveness of Hippotherapy Simulator on Balance and Knee Strength in People With Multiple Sclerosis: a Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-04-18Mindfulness-based Cognitive Therapy and Cognitive Behavioral Therapy for Chronic Pain in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-04-13Validity and Reliability of L Test in Persons With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-04-12Self-administered Hyperinsufflation Chest Mobilization Randomized Study on the Risk of Low Respiratory Infection in Patients With Multiple Sclerosis With Sputum Capacity Deficit
-
CLINICAL_TRIALS study record update · 2022-04-12Therapeutic Effects of Line Dancing in People With Multiple Sclerosis: an Evaluator-blinded, Randomized Controlled Study
-
CLINICAL_TRIALS study record update · 2022-04-08Virtual Reality-treadmill Combined Intervention for Enhancing Mobility and Cognitive Function in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-04-06Clinical Trial Phase I / II Multicenter, Randomized, Crossover, Double-blind Evaluation of the Safety and Feasibility of Systemic Therapy With Mesenchymal Cells Derived From Autologous Bone Marrow in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-04-05Muscle Strain in Multiple Sclerosis Patients Measured by Ultrasound Speckle Tracking
-
CLINICAL_TRIALS study record update · 2022-03-31CLOSER_MS: Communicating With Local or Distance Caregivers Offering Support and Electronic Resources
-
CLINICAL_TRIALS study record update · 2022-03-29Effects of Telerehabilitation-Based Pelvic Floor Muscle Training on Urinary Incontinence, Sexual Function and Quality of Life in People With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2022-03-24Analysis of Multiple Sclerosis Patients Who Have Had Greater Than 60 Infusions of Natalizumab: Safety and Efficacy